Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this retrospective observational study is to obtain information to confirm or
contradict the results of prior studies on domperidone and sudden cardiac death. The
population studied are the Saskatchewan residents who used domperidone or another type of
medication known as a Proton Pump Inhibitor (PPI) between 1990 and 2005. Information will be
collected from various sources including the Saskatchewan Health (SH) database and Cancer
Registry.
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.